BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Queensland Health
Cerilliant
Cantor Fitzgerald
Express Scripts
Harvard Business School
Healthtrust
Boehringer Ingelheim
Mallinckrodt

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 204435

« Back to Dashboard

NDA 204435 describes NEOMYCIN SULFATE, which is a drug marketed by Breckenridge Pharm, Bristol Myers Squibb, Lannett, Lannett Holdings Inc, Lilly, Roxane, Sandoz, Teva, X Gen Pharms, Bausch And Lomb, Pharmafair, Alcon Pharms Ltd, Fougera, and Pharmaderm, and is included in twenty NDAs. It is available from seven suppliers. Additional details are available on the NEOMYCIN SULFATE profile page.

The generic ingredient in NEOMYCIN SULFATE is neomycin sulfate; triamcinolone acetonide. There are nineteen drug master file entries for this compound. Additional details are available on the neomycin sulfate; triamcinolone acetonide profile page.
Summary for 204435
Tradename:NEOMYCIN SULFATE
Applicant:Lannett Holdings Inc
Ingredient:neomycin sulfate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 204435
Ingredient-typeAminoglycosides
Medical Subject Heading (MeSH) Categories for 204435
Suppliers and Packaging for NDA: 204435
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN SULFATE neomycin sulfate TABLET;ORAL 204435 ANDA Lannett Company, Inc. 0527-1210 0527-1210-01 100 TABLET in 1 BOTTLE, PLASTIC (0527-1210-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength500MG
Approval Date:Jun 10, 2016TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Moodys
Fuji
Baxter
Express Scripts
Mallinckrodt
Julphar
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot